UBiome

uBiome, Inc. was a biotechnology company based in San Francisco that developed technology to sequence the human microbiome. Its main product analyzed gut microbes in patients with long-term intestinal disorders. Founded in 2012, the company shut down in 2019 following an investigation into possible insurance fraud.

UBiome

uBiome, Inc. was a biotechnology company based in San Francisco that developed technology to sequence the human microbiome. Its main product analyzed gut microbes in patients with long-term intestinal disorders. Founded in 2012, the company shut down in 2019 following an investigation into possible insurance fraud.